Clinical trial
Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients…
NCT00319995 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00319995 |
|---|---|
| Title | Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED) |
| Official title | Efficacy and Safety of Combination Loratadine/Montelukast QD vs Pseudoephedrine and Placebo in the Treatment of Subjects With Seasonal Allergic Rhinitis |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | loratadine, montelukast |
| Enrollment | 1,095 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 28, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: